Common wart. Viral wart, unspecified
Conditions
Interventions
Intervention 1: Intervention group: carboxytherapy by injecting 2cc of carbon dioxide gas by MEDAION carboxytherapy device, made in Iran, Nik Fanavaran Plasma company subcutaneously for each wart lesi
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Informed consent to participate in the study Age greater than18 Both genders The presence of more than six recurrent common warts in one of the upper or lower limbs Distribution of lesions on both right and left sides At least 3 lesions on each side
Exclusion criteria
Exclusion criteria: Absence of pregnancy and breastfeeding No smoking, alcohol, and drug abuse Not to suffer from systemic diseases such as diabetes, kidney diseases, heart diseases, respiratory diseases, liver diseases, anemia, etc. Not having connective tissue diseases or genodermatosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of warts. Timepoint: At the beginning of the study (before the start of the intervention), and before each session (sessions 2, 3, 4, and 5), and two weeks after the last session. Method of measurement: Eye and digital camera. | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin scar. Timepoint: Before each session and two weeks after the last session. Method of measurement: Digital camera.;Pain at the treatment site. Timepoint: After each session. Method of measurement: Visual Analogue Scale.;Pigmentation. Timepoint: Before each session and two weeks after the last session. Method of measurement: Digital camera. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rafie
Arak University of Medical Sciences
Outcome results
None listed